This is manifested through various outcomes, including a decrease in cancer cell viability, initiation of DNA damage, cell cycle suspension, production of ROS, perturbation of mitochondrial transmembrane potential and obstruction of EGFR‐TKD. This evidence concerns the gene EGFR and cancer.